A recent study by Transparency Market Research (TMR) forecasts that the global dialysis products and services market will grow at a CAGR of 5.9% between 2014 and 2020. TMR, a market intelligence firm based in the United States, in its report states, that the global dialysis products and services market will reach a market value worth US$115474.9 million by 2020 from US$77607.7 million in 2013. The report titled ‘Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020’ is available for sale on the website. The TMR report identifies that the rising incidence of renal disorders and related conditions amongst the aging population has a significant impact on the overall demand for dialysis products and services. Government reimbursement policies for dialysis procedures and high incidence of diabetes and chronic kidney diseases are the other factors that drive the global dialysis products and services market.
Browse Full Press Release: http://www.transparencymarketresearch.com/pressrelease/dialysis-products-services-market.htm
The high incidence of kidney diseases can be attributed to inactive lifestyles, stress, smoking, and alcohol consumption. Dialysis as a life sustaining process, involves blood purification in patients affected by renal disorders. It removes the extra fluids and waste products from the blood and also controls the other fluidic levels in the patients’ body.According to the report, the global dialysis products and services market is segmented on the basis of product, service, and geography. Based on product, this market is categorized into hemodialysis products and peritoneal dialysis products. With a market share of almost 31%, the segment for hemodialysis machines held the highest share in the overall market for hemodialysis products in 2013.
The pressing need to adopt sophisticated treatment for chronic kidney diseases and rising incidence of renal disorders stimulates the demand for hemodialysis machines. Within the segment for peritoneal dialysis products, dialysates/concentrates occupy the highest market share. Surging demand for peritoneal dialysis fuels the demand for dialysates. On the basis of service, the global dialysis products and services market is segmented into home dialysis and in-center dialysis. Expansion of the segment for in-center dialysis can be attributed to the convenience in administering the course of treatment by skilled dialysis specialists in a regularized schedule. Geographically, this research report classifies the global dialysis products and services market into Asia Pacific, Europe, North America, and Rest of the World. In 2013, North America held the highest share in the global dialysis products and services market owing to widespread awareness about the treatment options and an increasing patient pool requiring dialysis. Some of the Asia Pacific economies such as India, Brazil, China, and Japan will prove to be potential markets in the forthcoming years owing to increasing income levels, greater government support for developing better healthcare infrastructure, and favorable reimbursement policies.
Browse the full Dialysis Products and Services Market [Hemodialysis Products, Peritoneal Dialysis Products; In-center Dialysis Services and Home Dialysis Services] - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/dialysis-products-services-market.html
It is anticipated that the robustly growing dialysis products and services market will give a significant boost to the global pharmaceuticals market during the forecast period.
The prominent companies operating in the global dialysis products and services market are Rockwell Medical Technologies Inc., NxStage Medical Inc., Nipro Corporation, Nikkiso Co. Ltd., Medical Components Inc., and Covidien plc.
The prominent companies operating in the global dialysis products and services market are Rockwell Medical Technologies Inc., NxStage Medical Inc., Nipro Corporation, Nikkiso Co. Ltd., Medical Components Inc., and Covidien plc.
No comments:
Post a Comment